Natriuresis and Diuresis Studies in people living with T2DM and obesity have shown that GLP-1 RA administration can induce diuresis and natriuresis [110, 111] that likely contribute to the renoprotective effects of GLP-1 RA
One Size Does Not Fit All: Understanding Microdosing Semaglutide for Diabetes in Multidose Pens
This medication has drastically changed my lifestyle, eating habits and stress behaviors
Learn more.
In the drugs best showing so far, the ATTAIN-1 trial, people taking orforglipron lost on average 12.4% of their baseline weight, a notch below the roughly 14% weight loss seen in similar trials of Novo Nordisks injectable Wegovy and also below the typical results seen with Eli Lillys tirzepatide, a dual GLP-1/GIP medication
Verma S, Petrie MC, Borlaug BA, Butler J, Davies MJ, Kitzman DW, et al